Citation Impact
Citing Papers
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
2005 Standout
Programmed cell death 1 ligand 1 and tumor-infiltrating CD8 + T lymphocytes are prognostic factors of human ovarian cancer
2007 StandoutNobel
Hallmarks of Cancer: The Next Generation
2011 Standout
Regulation of Type II Transmembrane Serine Proteinase TMPRSS6 by Hypoxia-inducible Factors
2010 StandoutNobel
Hypoxia-Inducible Factors in Physiology and Medicine
2012 StandoutNobel
Gene expression profiling predicts clinical outcome of breast cancer
2002 StandoutNature
Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis
1993 StandoutNature
Rearrangement of the BCL6 locus at 3q27 is an independent poor prognostic factor in nodal diffuse large B‐cell lymphoma
2002
The role of tumour‐associated macrophages in tumour progression: implications for new anticancer therapies
2002 Standout
The Clinical Significance of CD10 Antigen Expression in Diffuse Large B-Cell Lymphoma
2001
WAF1, a potential mediator of p53 tumor suppression
1993 Standout
Intratumoral T Cells, Recurrence, and Survival in Epithelial Ovarian Cancer
2003 Standout
Sulfasalazine, a potent suppressor of lymphoma growth by inhibition of the xc − cystine transporter: a new action for an old drug
2001
Clinicopathologic Analysis of CD10+ and CD10– Diffuse Large B-Cell Lymphoma
2001
Apoptosis by Death Factor
1997 Standout
HIF-1 mediates metabolic responses to intratumoral hypoxia and oncogenic mutations
2013 StandoutNobel
Clinical Epidemiological Quality in Molecular Genetic Research
1999
Genetic instabilities in human cancers
1998 StandoutNature
Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis
1998 StandoutNatureNobel
Involvement of chemokine receptors in breast cancer metastasis
2001 StandoutNature
Induction of Apoptotic Program in Cell-Free Extracts: Requirement for dATP and Cytochrome c
1996 Standout
CHOP Chemotherapy plus Rituximab Compared with CHOP Alone in Elderly Patients with Diffuse Large-B-Cell Lymphoma
2002 Standout
Lessons from Hereditary Colorectal Cancer
1996 Standout
The Pathogenesis of Rheumatoid Arthritis
2011 Standout
Lymphocyte Trafficking and Regional Immunity
1999
Macrophage Diversity Enhances Tumor Progression and Metastasis
2010 Standout
Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning
2002 Standout
Nuclear factor-κB in cancer development and progression
2006 StandoutNature
Immune Checkpoint Targeting in Cancer Therapy: Toward Combination Strategies with Curative Potential
2015 StandoutNobel
Four-and-a-Half LIM Domain Proteins Inhibit Transactivation by Hypoxia-inducible Factor 1
2012 StandoutNobel
Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death
2012 Standout
Immunohistochemical Expression Patterns of Germinal Center and Activation B-cell Markers Correlate With Prognosis in Diffuse Large B-cell Lymphoma
2004
Stem cells in tumor angiogenesis
2010
Inflammation and cancer: back to Virchow?
2001 Standout
Bcl-2 and Bcl-2-Related Proteins in Apoptosis Regulation
1995
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies
2007 Standout
Basic and Therapeutic Aspects of Angiogenesis
2011 Standout
Asymptomatic synovitis precedes clinically manifest arthritis
1998
Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray
2003 Standout
Oxygen Sensing, Homeostasis, and Disease
2011 StandoutNobel
Molecular profiling of diffuse large B-cell lymphoma identifies robust subtypes including one characterized by host inflammatory response
2004
The role of the bcl-2/ced-9 gene family in cancer and general implications of defects in cell death control for tumourigenesis and resistance to chemotherapy
1997
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies
2007 Standout
The occurrence and significance of V gene mutations in B cell—Derived human malignancy
2001
Pyruvate Kinase M2 Is a PHD3-Stimulated Coactivator for Hypoxia-Inducible Factor 1
2011 StandoutNobel
Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics
2009 StandoutNobel
Genetic Alterations of Cyclins, Cyclin-Dependent Kinases, and Cdk Inhibitors in Human Cancer
1996
Macrophages: Obligate Partners for Tumor Cell Migration, Invasion, and Metastasis
2006 Standout
Rearrangements of Bcl-1, Bcl-2, Bcl-6, and C-Myc in Diffuse Large B-Cell Lymphomas
2001
The detection and localization of monocyte chemoattractant protein-1 (MCP-1) in human ovarian cancer.
1995
CD10 and BCL-6 Expression in Paraffin Sections of Normal Lymphoid Tissue and B-Cell Lymphomas
2000
Defects in the Ubiquitin Pathway Induce Caspase-independent Apoptosis Blocked by Bcl-2
1998 StandoutNobel
The Bcl-2 Protein Family: Arbiters of Cell Survival
1998 StandoutScience
The gastric marginal zone B-cell lymphoma of MALT type
2000
Expression of a single gene, BCL-6, strongly predicts survival in patients with diffuse large B-cell lymphoma
2001
Activation-induced cytidine deaminase (AID) promotes B cell lymphomagenesis in Emu-cmyc transgenic mice
2007 StandoutNobel
Tumor immune escape mechanisms: impact of the neuroendocrine system
2006
Isolation and characterization of allelic losses and gains in colorectal tumors by arbitrarily primed polymerase chain reaction.
1992
Apoptosis in the Pathogenesis and Treatment of Disease
1995 StandoutScience
Prevention of Apoptosis by Bcl-2: Release of Cytochrome c from Mitochondria Blocked
1997 StandoutScience
Repeated observation of breast tumor subtypes in independent gene expression data sets
2003 Standout
Cancer Cell Cycles
1996 StandoutScience
Hypoxia-inducible factor 1 is a master regulator of breast cancer metastatic niche formation
2011 StandoutNobel
Nonimmunoglobulin (non-Ig)/BCL6gene fusion in diffuse large B-cell lymphoma results in worse prognosis than Ig/BCL6
2000
Death Receptors: Signaling and Modulation
1998 StandoutScience
Oxygen Sensing, Hypoxia-Inducible Factors, and Disease Pathophysiology
2013 StandoutNobel
Tumor suppressor p53 is a direct transcriptional activator of the human bax gene
1995 Standout
Quantitative assessment of the leukocyte infiltrate in ovarian cancer and its relationship to the expression of C-C chemokines.
1997
Molecular thanatopsis: a discourse on the BCL2 family and cell death
1996
Alteration of Lymphocyte Trafficking by Sphingosine-1-Phosphate Receptor Agonists
2002 StandoutScience
Nonimmunoglobulin (non-Ig)/BCL6gene fusion in diffuse large B-cell lymphoma results in worse prognosis than Ig/BCL6
2000
The Release of Cytochrome c from Mitochondria: A Primary Site for Bcl-2 Regulation of Apoptosis
1997 StandoutScience
Akt Phosphorylation of BAD Couples Survival Signals to the Cell-Intrinsic Death Machinery
1997 Standout
Histone demethylase JMJD2C is a coactivator for hypoxia-inducible factor 1 that is required for breast cancer progression
2012 StandoutNobel
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies
2007 Standout
The gastric marginal zone B-cell lymphoma of MALT type
2000
Chromosome Aberrations and Cancer
1991 Science
Phase II Study of Rituximab in Combination With CHOP Chemotherapy in Patients With Previously Untreated, Aggressive Non-Hodgkin’s Lymphoma
2001
Clinical impact of the differentiation profile assessed by immunophenotyping in patients with diffuse large B-cell lymphoma
2002
Bcl-2 and the regulation of programmed cell death
1994 Standout
Works of P.M. Kluin being referenced
Differentiation of follicular lymphoma cells after autologous bone marrow transplantation and haematopoietic growth factor treatment
1995
Overexpression of Intrinsic Hypoxia Markers HIF1α and CA-IX Predict for Local Recurrence in Stage T1-T2 Glottic Laryngeal Carcinoma Treated With Radiotherapy
2008
Gastric low-grade MALT lymphoma, high-grade MALT lymphoma and diffuse large B cell lymphoma show different frequencies of trisomy
1999
Subcellular Localization of bcl-2 Protein
1992
Somatic changes in B-lymphoproliferative disorders (B-LPD) detected by DNA-fingerprinting
1988
A new non-Hodgkin's B-cell line (DoHH2) with a chromosomal translocation t(14;18)(q32;q21).
1991
Joint scintigraphy for quantification of synovitis with 99mTc-labelled human immunoglobulin G compared to histological examination.
1995
Clinical Relevance of BCL2, BCL6, and MYC Rearrangements in Diffuse Large B-Cell Lymphoma
1998
Preferential expression of the mucosal homing receptor integrin alpha 4 beta 7 in gastrointestinal non-Hodgkin's lymphomas.
1997
Clinical Relevance of BCL2, BCL6, and MYC Rearrangements in Diffuse Large B-Cell Lymphoma
1998
Tumor infiltrating cells in human cancer. On the possible role of CD16+ macrophages in antitumor cytotoxicity.
1992
Bcl-2/JH rearrangements in benign lymphoid tissues with follicular hyperplasia.
1991
Multiple breakpoints within the BCL-1 locus in B-cell lymphoma: rearrangements of the cyclin D1 gene.
1993